Issar Pharmaceuticals Private Limited

Develops and sells peptide-based healthcare products, including a topical for burn wounds.

1995 | Hyderabad, Telangana (India) | Converted to LLP
Last Updated:

Issar Pharmaceuticals Profile

Key Indicators

  • Authorised Capital ₹ 55.00 Cr
  • Paid Up Capital ₹ 55.00 Cr
  • Company Age 29 Year, 4 Months
  • Last Filing with ROC 31 Mar 2022
  • Satisfied Charges ₹ 28.25 Cr
  • Revenue Growth -98.03%
  • Profit Growth -105.85%
  • Ebitda -136.00%
  • Net Worth -0.71%
  • Total Assets -4.83%

About Issar Pharmaceuticals

Issar Pharmaceuticals Private Limited (IPPL) is Converted To Llp company established on 31 Oct 1995 with its office registered at Hyderabad, Telangana, India and has been running since 29 Year, 4 Months with a paid up capital of 55.00 Cr. According to MCA records, 2 Directors are linked to this company as of 11 Dec 2024.

Company Details

  • Location

    Hyderabad, Telangana, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24239TG1995PTC022131

  • Company No.

    022131

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    31 Oct 1995

  • Date of AGM

    30 Sep 2022

  • Date of Balance Sheet

    31 Mar 2022

  • Listing Status

    Unlisted

  • ROC Code

    Roc Hyderabad

Industry

Pharma

Who are the key members and board of directors at Issar Pharmaceuticals?

Board Members (2)

NameDesignationAppointment DateStatus
Rama Isanaka Country flag representing In Director 02-Sep-1999Current
Isanaka Shaalini Country flag representing In Director 12-Apr-2016Current

Financial Performance of Issar Pharmaceuticals.

Issar Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 98.03% decrease. The company also saw a substantial fall in profitability, with a 105.85% decrease in profit. The company's net worth dipped by a decrease of 0.71%.

Issar Pharmaceuticals revenue growth over time
Issar Pharmaceuticals profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-98.03%
Revenue from Operations
-100.00%
Total Assets
-4.83%
Profit or Loss
-105.85%
Net Worth
-0.71%
EBITDA
-136.00%

What is the Ownership and Shareholding Structure of Issar Pharmaceuticals?

In 2022, Issar Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹0

Satisfied Charges

₹28.25 Cr

Charges Breakdown by Lending Institutions

  • State Bank Of India : 24.20 Cr
  • Technology Development Board : 2.75 Cr
  • Uti Bank Limited : 1.00 Cr
  • The Karnataka Bank Limited : 0.25 Cr
  • Karnataka Bank : 0.05 Cr

Latest Charge Details

DateLenderAmountStatus
16 Jun 2011State Bank Of India₹24.20 CrSatisfied
05 Jun 2006Uti Bank Limited₹1.00 CrSatisfied
12 Nov 2005The Karnataka Bank Limited₹0.00Satisfied
12 Nov 2005The Karnataka Bank Limited₹2.50 MSatisfied
19 Nov 2003Karnataka Bank₹0.53 MSatisfied

How Many Employees Work at Issar Pharmaceuticals?

Unlock and access historical data on people associated with Issar Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Issar Pharmaceuticals Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Issar Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Issar Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Issar Pharmaceuticals

Recent activity within the organization

  • Annual General Meeting

    Issar Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records.

  • Balance Sheet

    Issar Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Hyderabad.

  • Charges

    A charge registered on 16 Jun 2011 via Charge ID 10294014 with State Bank Of India was fully satisfied on 17 Jun 2016.

  • Director Appointment

    Isanaka Shaalini was appointed as a Director was appointed as a Director on 12 Apr 2016 & has been associated with this company since 8 years 11 months .

  • Charges

    A charge with State Bank Of India amounted to Rs. 24.20 Cr with Charge ID 10294014 was registered on 16 Jun 2011.

  • Charges

    A charge registered on 05 Jun 2006 via Charge ID 10006700 with Uti Bank Limited was fully satisfied on 07 Jun 2011.

Frequently asked questions

  • What is the Incorporation or founding date of Issar Pharmaceuticals Private Limited?

    Issar Pharmaceuticals Private Limited was incorporated on 31 Oct 1995.

  • What is authorized share capital and paid-up capital of Issar Pharmaceuticals Private Limited?

    The authorized share capital of Issar Pharmaceuticals Private Limited is ₹ 55.00 Cr and paid-up capital is ₹ 55.00 Cr.

  • Who are the current board members & directors of Issar Pharmaceuticals Private Limited?

    Currently 2 directors are associated with Issar Pharmaceuticals Private Limited.

    • Rama Krishna Reddy Isanaka
    • Isanaka Shaalini

  • What is the registered address of Issar Pharmaceuticals Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Issar Pharmaceuticals Private Limited is H. No. 8-2-334 Serene Chambers Flat W - 301 302 Road No.5, Banja Ra Hills India, Hyderabad, Telangana, 500034.

  • What is the corporate identification number (CIN) and company number of Issar Pharmaceuticals Private Limited?

    The corporate identification number (CIN) of Issar Pharmaceuticals Private Limited is U24239TG1995PTC022131 and the company number is 022131 as per Ministry of Corporate Affairs (MCA).

  • What is the official website of Issar Pharmaceuticals Private Limited?

    The Official website of Issar Pharmaceuticals Private Limited is https://www.issar.co.in

  • What has been the recent revenue trend for Issar Pharmaceuticals Private Limited?

    According to the financial reports for the fiscal year 2022, the revenue trend for Issar Pharmaceuticals Private Limited has fallen by -98.03%.

  • What change has been observed in the net worth of Issar Pharmaceuticals Private Limited, and by what percentage?

    The financial reports for the fiscal year 2022 indicates that The net worth of Issar Pharmaceuticals Private Limited has experienced an downturn of -0.71%.

  • When was the last Balance Sheet of Issar Pharmaceuticals Private Limited filed with the ROC?

    The most recent Balance Sheet for Issar Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2022.

People also Viewed